CYCN logo

Cyclerion Therapeutics (CYCN) CAPEX

Annual CAPEX

N/A

31 December 2023

CYCN CAPEX Chart

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Quarterly CAPEX

N/A

30 September 2024

CYCN Quarterly CAPEX Chart

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

TTM CAPEX

N/A

30 September 2024

CYCN TTM CAPEX Chart

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

CYCN CAPEX Performance

PeriodPeriodAnnualAnnualQuarterlyQuarterlyTTMTTM
1 y1 year---
3 y3 years---
5 y5 years---

CYCN CAPEX High & Low

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs lowTTM vs highTTM vs highTTM vs lowTTM vs low
3 y3 years
5 y5 years
alltimeall time

Cyclerion Therapeutics CAPEX History

DateAnnualQuarterlyTTM
Dec 2021
$7000.00(-99.5%)
$0.00(-100.0%)
$7000.00(-83.3%)
Sept 2021
-
$7000.00(-80.0%)
$42.00 K(-97.2%)
Dec 2020
$1.52 M
$35.00 K(+288.9%)
$1.52 M(-8.4%)
Sept 2020
-
$9000.00(-88.0%)
$1.66 M(-27.9%)
DateAnnualQuarterlyTTM
June 2020
-
$75.00 K(-94.7%)
$2.31 M(-64.4%)
Mar 2020
-
$1.41 M(+707.5%)
$6.48 M(+27.7%)
Dec 2019
$6.89 M
$174.00 K(-73.4%)
$5.07 M(+3.6%)
Sept 2019
-
$653.00 K(-84.6%)
$4.90 M(+15.4%)
June 2019
-
$4.25 M
$4.25 M

FAQ

  • What is the all time high annual CAPEX for Cyclerion Therapeutics?
  • What is the all time high quarterly CAPEX for Cyclerion Therapeutics?
  • What is the all time high TTM CAPEX for Cyclerion Therapeutics?

What is the all time high annual CAPEX for Cyclerion Therapeutics?

Cyclerion Therapeutics all-time high annual capital expenditures is $6.89 M

What is the all time high quarterly CAPEX for Cyclerion Therapeutics?

Cyclerion Therapeutics all-time high quarterly capital expenditures is $4.25 M

What is the all time high TTM CAPEX for Cyclerion Therapeutics?

Cyclerion Therapeutics all-time high TTM capital expenditures is $6.48 M